CEO Robert Ball was paid $1,202,483 in fiscal year 2025, ↑ up 91.4% from fiscal year 2024 (SEC filing 0001699350-26-000026 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$1,202,483 ↑ Robert Ball total, FY2025 | — CEO pay percentile vs peers | — CEO-to-median pay ratio | — Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
Ask our research desk — $99, 24h, every figure cited to its filing.
SI's next annual pay disclosure, estimated April 29, 2027.est. Filing ↗
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Robert Ball | $467,944 | $0 | $0 | $494,126 | $224,613 | $0 | $15,800 | $1,202,483 |
| Chief Executive Officer and Executive Chairman | ||||||||
| David Blue | 364,455 | 0 | 0 | 148,238 | 247,101 | 0 | 18,977 | 778,771 |
| Chief Customer Experience Officer | ||||||||
| Jeffrey Points | 378,144 | 50,000 | — | 98,825 | 181,509 | — | 11,338 | 719,816 |
| Chief Financial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Robert Ball | $1,202,483 | $628,114 | — | ↑ +574,369 |
| David Blue | 778,771 | — | — | — |
| Jeffrey Points | 719,816 | 507,812 | — | ↑ +212,004 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read SHOULDER INNOVATIONS, INC.'s Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper SI reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
Get the SHOULDER INNOVATIONS, INC. Peer Teardown Report
$1,202,483 Robert Ball total, FY2025
$199
The free page is the headline. The teardown reads every company in the disclosed peer group on its own numbers.
Data as of October 6, 2026 · Source: 0001699350-26-000026 · Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
Reports for SI
Every report below is generated from the same filings as the free brief above, at the moment of purchase. What each one adds:
Order SI
Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.
How we handle your data → Privacy
This is the complete answer, not a partial one — the list is never padded.
Get the SHOULDER INNOVATIONS, INC. Executive Compensation Report
$1,500
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2025 total |
|---|---|---|
| Andrew Hykes | Independent Director | — |
| Casey Tansey | Independent Director | $138,948 |
| Geoff Pardo | Former director (through FY2025) | $141,032 |
| Kevin Sidow | Independent Director | $215,993 |
| Matthew Ahearn | Director | — |
| Michael Carusi | Independent Director | $133,740 |
| Paul Buckman | Lead Independent Director | $203,528 |
| Richard J. Buchholz | Independent Director | $142,073 |
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Robert Ball | Director | 2026-04-30 | D | 10,000 | $0 | $0 | Derivative, Class A Common | Form 4 ↗ |
| Robert Ball | Director | 2026-04-30 | A | 10,000 | 2 | 24,804 | Common | Form 4 ↗ |
| Matthew Ahearn | Director | 2026-06-12 | D | 15,856 | 19 | 296,185 | Common, open-market sale | Form 4 ↗ |
| Matthew Ahearn | Director | 2026-06-15 | D | 2,500 | 19 | 48,148 | Common, open-market sale | Form 4 ↗ |
| Matthew Ahearn | Director | 2026-06-15 | D | 1,644 | 18 | 29,922 | Common, open-market sale | Form 4 ↗ |
| Andrew Hykes | Director | 2026-06-26 | A | 5,046 | 0 | 0 | RSU | Form 4 ↗ |
| Kevin Sidow | Director | 2026-06-26 | A | 5,046 | 0 | 0 | RSU | Form 4 ↗ |
| Casey Tansey | Director | 2026-06-26 | A | 5,046 | 0 | 0 | RSU | Form 4 ↗ |
| Richard J. Buchholz | Director | 2026-06-26 | A | 5,046 | 0 | 0 | RSU | Form 4 ↗ |
| Paul Buckman | Director | 2026-06-26 | A | 5,046 | 0 | 0 | RSU | Form 4 ↗ |
| Gilde Healthcare Holding B.V. | Greater-than-10% holder | 2026-07-30 | D | 28,245 | 23 | 659,803 | Common, indirect | Form 4 ↗ |
| Gilde Healthcare Holding B.V. | Greater-than-10% holder | 2026-07-31 | D | 20,034 | 23 | 455,373 | Common, indirect | Form 4 ↗ |
| Gilde Healthcare Holding B.V. | Greater-than-10% holder | 2026-08-03 | D | 10,751 | 23 | 244,155 | Common, indirect | Form 4 ↗ |
| Gilde Healthcare Holding B.V. | Greater-than-10% holder | 2026-08-04 | D | 99,812 | 23 | 2,272,719 | Common, indirect | Form 4 ↗ |
| Gilde Healthcare Holding B.V. | Greater-than-10% holder | 2026-08-05 | D | 7,338 | 23 | 166,132 | Common, indirect | Form 4 ↗ |
| Gilde Healthcare Holding B.V. | Greater-than-10% holder | 2026-08-06 | D | 2,095 | 23 | 47,347 | Common, indirect | Form 4 ↗ |
| Matthew Ahearn | Director | 2026-08-14 | D | 2,500 | 0 | 0 | Common | Form 4 ↗ |
| Matthew Ahearn | Director | 2026-08-17 | D | 8,314 | 20 | 167,101 | Common, open-market sale | Form 4 ↗ |
| Matthew Ahearn | Director | 2026-08-18 | D | 12,586 | 21 | 263,493 | Common, open-market sale | Form 4 ↗ |
| Matthew Ahearn | Director | 2026-08-18 | D | 1,600 | 21 | 34,211 | Common, open-market sale | Form 4 ↗ |
| Gilde Healthcare Holding B.V. | Greater-than-10% holder | 2026-08-20 | D | 3,900 | 23 | 88,140 | Common, indirect | Form 4 ↗ |
| Gilde Healthcare Holding B.V. | Greater-than-10% holder | 2026-08-21 | D | 20,516 | 23 | 463,867 | Common, indirect | Form 4 ↗ |
| Gilde Healthcare Holding B.V. | Greater-than-10% holder | 2026-08-24 | D | 681 | 23 | 15,404 | Common, indirect | Form 4 ↗ |
| Gilde Healthcare Holding B.V. | Greater-than-10% holder | 2026-08-26 | D | 1,196 | 23 | 27,030 | Common, indirect | Form 4 ↗ |
| Robert Ball | Director | 2026-09-14 | D | 10,175 | 18 | 187,706 | Common, open-market sale | Form 4 ↗ |
| Robert Ball | Director | 2026-09-14 | A | 89,233 | 2 | 187,282 | Common | Form 4 ↗ |
| Robert Ball | Director | 2026-09-14 | D | 89,233 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Paul Buckman | Director | 2026-10-05 | A | 1,275 | 20 | 24,990 | Common | Form 4 ↗ |
| Andrew Hykes | Director | 2026-10-05 | A | 669 | 20 | 13,112 | Common | Form 4 ↗ |
| Kevin Sidow | Director | 2026-10-05 | A | 892 | 20 | 17,483 | Common | Form 4 ↗ |
| Casey Tansey | Director | 2026-10-05 | A | 733 | 20 | 14,367 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| David Blue | OPTION | 2025-04-23 | — | — | 51,795 | — | $148,238 |
| Jeffrey Points | OPTION | 2025-04-23 | — | — | 34,530 | — | 98,825 |
| Robert Ball | OPTION | 2025-04-23 | — | — | 172,650 | — | 494,126 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| David Blue | $0 | $0 | $148,238 | 0.0% |
| Jeffrey Points | 0 | 0 | 98,825 | 0.0% |
| Robert Ball | 0 | 0 | 494,126 | 0.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Jeffrey Points | Option | 34,530 | 2.86 | — |
| David Blue | Option | 9,352 | 2.48 | — |
| Robert Ball | Option | 183,438 | 2.1 | — |
| Robert Ball | Option | 172,650 | 2.86 | — |
| Robert Ball | Option | 116,789 | 2.48 | — |
| Jeffrey Points | Option | 46,426 | 2.48 | — |
| David Blue | Option | 51,795 | 2.86 | — |
| CEO STI target (% of salary) | 50% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | FW Cook |
| Clawback policy | Adopted in July 2025. Applies to current and former executive officers. Requires recovery of incentive-based compensation erroneously awarded in the event of an accounting restatement due to material noncompliance with financial reporting requirements. Covers compensation granted, earned, or vested based on financial reporting measures received during the applicable three-year period. Recovery may be deemed impractical at Compensation Committee discretion. |
| Anti-hedging | The Insider Trading Policy specifically prohibits hedging transactions, engaging in transactions in puts, calls or other derivative securities involving the Company's equity securities, and short sales. |
| Anti-pledging | True |
| Ratio (CEO : median employee) | — |
|---|---|
| CEO total compensation | — |
| Median employee compensation | — |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Kevin SidowIndependent · Audit · Compensation (Chair) | $49,167 | $114,990 | $51,836 | $0 | $0 | $215,993 |
| Paul BuckmanIndependent · Lead Independent Director · Audit · Nominating/Governance (Chair) | 45,000 | 114,990 | 43,538 | 0 | 0 | 203,528 |
| Richard J. BuchholzIndependent · Audit (Chair) · Nominating/Governance | 27,083 | 114,990 | — | 0 | 0 | 142,073 |
| Geoff PardoIndependent · Departed during FY | 26,042 | 114,990 | — | 0 | 0 | 141,032 |
| Casey TanseyIndependent · Compensation · Nominating/Governance | 23,958 | 114,990 | — | 0 | 0 | 138,948 |
| Michael CarusiIndependent · Not standing for re-election | 18,750 | 114,990 | — | 0 | 0 | 133,740 |
| Andrew HykesIndependent · Compensation · Newly elected | 0 | 0 | 0 | 0 | 0 | 0 |
| Robert BallEmployee director · Board Chair | 0 | 0 | 0 | — | 0 | 0 |
| Matthew AhearnEmployee director | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $45,000 |
|---|---|
| Annual equity retainer | $115,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 10,000 / 7,500 / 5,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $190,000 |
| Equity awards (grant-date value) | $689,940 |
| All other compensation | $0 |
| Total cost of the board | $879,940 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | SHOULDER INNOVATIONS, INC. | 2025 | Robert Ball | $467,944 | $0 | $494,126 | $224,613 | $1,202,483 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Robert Ball | DEF 14A | 2026-04-29 | 0001699350-26-000026 | Section “Summary Compensation Table for 2025 and 2024”. As printed: 1,202,483. Filing ↗machine: r2 · c21 · span 279096–279105 |
| 2 | Section 01, David Blue | DEF 14A | 2026-04-29 | 0001699350-26-000026 | Section “Summary Compensation Table for 2025 and 2024”. As printed: 778,771. Filing ↗machine: r6 · c21 · span 286634–286641 |
| 3 | Section 01, Jeffrey Points | DEF 14A | 2026-04-29 | 0001699350-26-000026 | Section “Summary Compensation Table for 2025 and 2024”. As printed: 719,816. Filing ↗machine: r4 · c21 · span 282861–282868 |
| 4 | Section 03, David Blue OPTION | DEF 14A | 2026-04-29 | 0001699350-26-000026 | Section “EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t37 · r6 · c4 · span 285945–285952 |
| 5 | Section 03, Jeffrey Points OPTION | DEF 14A | 2026-04-29 | 0001699350-26-000026 | Section “EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t37 · r4 · c4 · span 282173–282179 |
| 6 | Section 03, Robert Ball OPTION | DEF 14A | 2026-04-29 | 0001699350-26-000026 | Section “EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t37 · r2 · c4 · span 278329–278336 |
| 7 | Section 07, pay ratio | 10-K | 2026-03-10 | 0001699350-26-000011 | Section “CEO Pay Ratio”. As printed: —. Filing ↗ |
| 8 | Section 08, Kevin Sidow | DEF 14A | 2026-04-29 | 0001699350-26-000026 | Section “Director Compensation”. As printed: 215,993. Filing ↗machine: t32 · r6 · c7 · span 246536–246758 |
| 9 | Section 08, Paul Buckman | DEF 14A | 2026-04-29 | 0001699350-26-000026 | Section “Director Compensation”. As printed: 203,528. Filing ↗machine: t32 · r3 · c7 · span 242099–242321 |
| 10 | Section 08, Richard J. Buchholz | DEF 14A | 2026-04-29 | 0001699350-26-000026 | Section “Director Compensation”. As printed: 142,073. Filing ↗machine: t32 · r2 · c7 · span 240519–240772 |
| 11 | Section 08, Geoff Pardo | DEF 14A | 2026-04-29 | 0001699350-26-000026 | Section “Director Compensation”. As printed: 141,032. Filing ↗machine: t32 · r5 · c7 · span 245200–245422 |
| 12 | Section 08, Casey Tansey | DEF 14A | 2026-04-29 | 0001699350-26-000026 | Section “Director Compensation”. As printed: 138,948. Filing ↗machine: t32 · r7 · c7 · span 247874–248096 |
| 13 | Section 08, Michael Carusi | DEF 14A | 2026-04-29 | 0001699350-26-000026 | Section “Director Compensation”. As printed: 133,740. Filing ↗machine: t32 · r4 · c7 · span 243651–243873 |
| 14 | Section 08, Andrew Hykes | DEF 14A | 2026-04-29 | 0001699350-26-000026 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 15 | Section 08, Robert Ball | DEF 14A | 2026-04-29 | 0001699350-26-000026 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 16 | Section 08, Matthew Ahearn | DEF 14A | 2026-04-29 | 0001699350-26-000026 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 17 | Section 02, Robert Ball 2026-04-30 | Form 4 | 2026-04-30 | 0002070664-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 18 | Section 02, Robert Ball 2026-04-30 | Form 4 | 2026-04-30 | 0002070664-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 19 | Section 02, Matthew Ahearn 2026-06-12 | Form 4 | 2026-06-16 | 0002070582-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 20 | Section 02, Matthew Ahearn 2026-06-15 | Form 4 | 2026-06-16 | 0002070582-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 21 | Section 02, Matthew Ahearn 2026-06-15 | Form 4 | 2026-06-16 | 0002070582-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 22 | Section 02, Andrew Hykes 2026-06-26 | Form 4 | 2026-06-29 | 0001806431-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 23 | Section 02, Kevin Sidow 2026-06-26 | Form 4 | 2026-06-29 | 0002072468-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 24 | Section 02, Casey Tansey 2026-06-26 | Form 4 | 2026-06-29 | 0001628280-26-046099 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 25 | Section 02, Richard J. Buchholz 2026-06-26 | Form 4 | 2026-06-29 | 0001737133-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 26 | Section 02, Paul Buckman 2026-06-26 | Form 4 | 2026-06-29 | 0001215243-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 27 | Section 02, Gilde Healthcare Holding B.V. 2026-07-30 | Form 4 | 2026-08-03 | 0001193125-26-330846 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 28 | Section 02, Gilde Healthcare Holding B.V. 2026-07-31 | Form 4 | 2026-08-03 | 0001193125-26-330846 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 29 | Section 02, Gilde Healthcare Holding B.V. 2026-08-03 | Form 4 | 2026-08-05 | 0001193125-26-335278 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 30 | Section 02, Gilde Healthcare Holding B.V. 2026-08-04 | Form 4 | 2026-08-05 | 0001193125-26-335278 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 31 | Section 02, Gilde Healthcare Holding B.V. 2026-08-05 | Form 4 | 2026-08-07 | 0001193125-26-340260 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 32 | Section 02, Gilde Healthcare Holding B.V. 2026-08-06 | Form 4 | 2026-08-07 | 0001193125-26-340260 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 33 | Section 02, Matthew Ahearn 2026-08-14 | Form 4 | 2026-08-18 | 0002070582-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 34 | Section 02, Matthew Ahearn 2026-08-17 | Form 4 | 2026-08-18 | 0002070582-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 35 | Section 02, Matthew Ahearn 2026-08-18 | Form 4 | 2026-08-18 | 0002070582-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 36 | Section 02, Matthew Ahearn 2026-08-18 | Form 4 | 2026-08-18 | 0002070582-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 37 | Section 02, Gilde Healthcare Holding B.V. 2026-08-20 | Form 4 | 2026-08-24 | 0001193125-26-363913 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 38 | Section 02, Gilde Healthcare Holding B.V. 2026-08-21 | Form 4 | 2026-08-24 | 0001193125-26-363913 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 39 | Section 02, Gilde Healthcare Holding B.V. 2026-08-24 | Form 4 | 2026-08-24 | 0001193125-26-363913 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, Gilde Healthcare Holding B.V. 2026-08-26 | Form 4 | 2026-08-28 | 0001193125-26-374359 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, Robert Ball 2026-09-14 | Form 4 | 2026-09-14 | 0002070664-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, Robert Ball 2026-09-14 | Form 4 | 2026-09-14 | 0002070664-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, Robert Ball 2026-09-14 | Form 4 | 2026-09-14 | 0002070664-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, Paul Buckman 2026-10-05 | Form 4 | 2026-10-06 | 0001215243-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 02, Andrew Hykes 2026-10-05 | Form 4 | 2026-10-06 | 0001806431-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 46 | Section 02, Kevin Sidow 2026-10-05 | Form 4 | 2026-10-06 | 0002072468-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 47 | Section 02, Casey Tansey 2026-10-05 | Form 4 | 2026-10-06 | 0001628280-26-065260 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 48 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 49 | Section 03b vehicle mix (computed) | Computed | — | — | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 50 | Section 09b board cost (computed) | Computed | — | — | Cash 190,000 + equity 689,940 + all other 0 = 879,940, summed across the director compensation table rows.machine: formula: Σ = 879,940 |
| 51 | SHOULDER INNOVATIONS, INC. (subject), Section 10b CEO total | DEF 14A | 2026-04-29 | 0001699350-26-000026 | CEO total compensation as printed in SHOULDER INNOVATIONS, INC.'s own proxy. As printed: 1,202,483. Filing ↗machine: r2 · c21 · span 279096–279105 |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.
Get the SHOULDER INNOVATIONS, INC. Executive Compensation Report
$1,500